FDA Adverse Event Injury Summary report: N

OMNIPOD INSULIN MANAGEMENT SYSTEM

MDR report key: 15234464 · Received August 16, 2022

Report

Report Number
3004464228-2022-14740
Event Type
Injury
Date Received
August 16, 2022
Date of Event
August 6, 2022
Report Date
August 12, 2022
Manufacturer
INSULET CORPORATION
Product Code
LZG
UDI-DI
20385081120057
PMA / PMN Number
K192659
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE HAS NOT BEEN RETURNED/RECEIVED TO DATE. IF THE DEVICE IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED WITH THE INVESTIGATION RESULTS. WE ARE UNABLE TO DETERMINE IF ANY PRODUCT CONDITION COULD HAVE CONTRIBUTED TO CUSTOMER'S INFUSION SITE INFECTION. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. THE OMNIPOD IS ISO10993 COMPLIANT, UNDERGOING CYTOTOXICITY, SENSITIZATION, GENOTOXICITY, HEMOLYSIS, IRRITATION OR INTRACUTANEOUS REACTIVITY, SYSTEMIC TOXICITY, AND IMPLANTATION EFFECTS TESTING. THE OMNIPOD IS STERILIZED WITH 100% ETHYLENE OXIDE GAS WITH A STERILITY ASSURANCE LEVEL OF 10-6  PER ISO11135  AND EO RESIDUAL LEVELS IN COMPLIANCE WITH ISO10993. EACH LOT  IS CONFIRMED TO MEET REQUIREMENTS FOR NON-PYROGENICITY PER ISO10993 AND STERILITY PER ISO11135 PRIOR TO RELEASE.

Additional Manufacturer Narrative · 0

CORRECTION TO D(4): CATALOG NO CHANGED FROM UNAVAILABLE TO ZXP425. CORRECTION TO G(5): PMA/510(K) # CHANGED FROM UNAVAILABLE TO K192659.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT WENT TO THEIR DOCTOR AND WAS DIAGNOSED WITH A BACTERIAL INFECTION. FOR TREATMENT, THE PATIENT WAS PRESCRIBED SULFAMETHOXAZOLE AT 2 TIMES PER DAY FOR 7 DAYS AND THE SITE WAS DRAINED. THE PATIENT WAS ADVISED TO TAKE TRAMADOL AT 50 MG STRENGTH. THE POD WAS WORN BETWEEN 4 AND 24 HOURS ON UNKNOWN LOCATION. THE PATIENT WAS DISCHARGED AFTER 1 HOUR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1916852 OMNIPOD INSULIN MANAGEMENT SYSTEM PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 18025 L71335 20385081120057

Patients

Seq Age Sex Outcome Treatment
1 27 YR Female Required Intervention